We are live on ! Find out more
AHL

Abel Hall LLC Portfolio holdings

AUM $579M
1-Year Est. Return 54.21%
This Fund
S&P 500
This Quarter Est. Return
+26.06%
1 Year Est. Return
+54.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$579M
AUM Growth
+$109M
Cap. Flow
+$34.2M
Cap. Flow %
5.91%
Top 10 Hldgs %
25.32%
Holding
1,093
New
282
Increased
378
Reduced
228
Closed
138

Top Sells

Rank Stock Value
1
TM icon
Toyota
TM
+$1.03M
2
APA icon
APA Corp
APA
+$1.01M
3
MRK icon
Merck
MRK
+$950K
4
T icon
AT&T
T
+$808K
5
WDS icon
Woodside Energy
WDS
+$777K

Sector Composition

Rank Sector Weight
1 Technology 19.99%
2 Financials 9.6%
3 Healthcare 8.6%
4 Industrials 8.26%
5 Consumer Discretionary 5.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVTR icon
826
Avantor
AVTR
$8.48B
$108K 0.02%
+10,875
New +$93.6K
SHLS icon
827
Shoals Technologies Group
SHLS
$1.43B
$107K 0.02%
10,835
+3
+0% +$27
FRSH icon
828
Freshworks
FRSH
$3.09B
$106K 0.02%
+10,428
New +$92.9K
GDYN icon
829
Grid Dynamics Holdings
GDYN
$513M
$105K 0.02%
+18,522
New +$115K
IOVA icon
830
Iovance Biotherapeutics
IOVA
$2.1B
$104K 0.02%
25,119
+713
+3% +$2.71K
OTF
831
Blue Owl Technology Finance Corp
OTF
$4.66B
$104K 0.02%
10,000
SBET icon
832
Sharplink Inc
SBET
$1.35B
$103K 0.02%
+21,512
New +$138K
NAVI icon
833
Navient
NAVI
$822M
$103K 0.02%
12,082
-2,997
-20% -$25.2K
LZ icon
834
LegalZoom.com
LZ
$1.39B
$101K 0.02%
+16,430
New +$101K
ARDT
835
Ardent Health
ARDT
$1.64B
$100K 0.02%
10,196
+14
+0.1% +$133
NXDR
836
Nextdoor Holdings
NXDR
$877M
$99.6K 0.02%
43,892
-8,445
-16% -$15.8K
IBRX icon
837
ImmunityBio
IBRX
$7.3B
$98.1K 0.02%
11,204
-8,609
-43% -$65.2K
FATE icon
838
Fate Therapeutics
FATE
$270M
$96.9K 0.02%
35,872
-876
-2% -$1.62K
CRCT icon
839
Cricut
CRCT
$985M
$96.5K 0.02%
+21,973
New +$94K
ETW
840
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.02B
$96.4K 0.02%
10,000
WVE icon
841
Wave Life Sciences
WVE
$1.13B
$96.3K 0.02%
+16,569
New +$110K
NIQ
842
NIQ Global Intelligence PLC
NIQ
$3.45B
$94.8K 0.02%
+10,140
New +$98K
IKT icon
843
Inhibikase Therapeutics
IKT
$363M
$94.1K 0.02%
46,352
+31,789
+218% +$56.9K
ABR icon
844
Arbor Realty Trust
ABR
$979M
$93.6K 0.02%
+17,277
New +$112K
BTG icon
845
B2Gold
BTG
$5.12B
$93.5K 0.02%
25,000
PBYI icon
846
Puma Biotechnology
PBYI
$406M
$93.4K 0.02%
11,520
+46
+0.4% +$337
BORR
847
Borr Drilling
BORR
$1.2B
$93.4K 0.02%
22,608
-2,654
-11% -$14.3K
BBAI icon
848
BigBear.ai
BBAI
$1.32B
$92.5K 0.02%
+25,200
New +$101K
EVGO icon
849
EVgo
EVGO
$230M
$91.2K 0.02%
47,732
-3,027
-6% -$6.1K
HRTX icon
850
Heron Therapeutics
HRTX
$92M
$91K 0.02%
213,185
+196,278
+1,161% +$157K

Similar funds

Abel Hall LLC's Q2 2026 Portfolio in Review

As of Q2 2026, Abel Hall LLC held 1,093 positions worth $579M, up 23% from $469M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Abel Hall LLC deployed $34.2M of net new capital in Q2 2026, opening 282 new positions and adding to 378 existing holdings. Its largest new stake was Brighthouse Financial: 15,398 shares worth $975K.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Merck, an estimated $950K trimmed.

  • Abel Hall LLC's largest Q2 2026 buy was Brighthouse Financial: 15,398 shares worth $975K.
  • Abel Hall LLC added most to Microsoft in Q2 2026, an estimated $2.57M increase.
  • Abel Hall LLC's biggest Q2 2026 reduction was Merck, cutting an estimated $950K.
  • Abel Hall LLC fully exited Toyota in Q2 2026, selling an estimated $1.03M.
  • Abel Hall LLC's ten largest holdings make up 25% of its $579M portfolio in Q2 2026.
  • Abel Hall LLC opened 282 new positions and closed 138 in Q2 2026.
  • Abel Hall LLC's portfolio value rose 23% quarter-over-quarter to $579M.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.